Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CIGA Healthcare is a private UK diagnostics and medical device company focused on rapid test products for over-the-counter, professional, and veterinary use. Founded in 2005 and headquartered in Ballymena, Northern Ireland, the company markets products under its Suresign brand and sells into pharmacies, healthcare providers, and distributors in more than 70 countries. Its portfolio includes pregnancy, diabetes, cholesterol, COVID-19 antibody, and veterinary rapid diagnostic tests, and the company has emphasized quality systems including ISO 13485 compliance and CE-marked/FDA-approved products where applicable. CIGA also operates a US subsidiary, CIGA Healthcare LLC, to support its American market presence. Recent public information indicates the company is collaborating with Ulster University on novel diagnostics for heart failure and dementia while continuing to expand commercial distribution in Europe and the US.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CIGA Healthcare.